BetterLife Pharma Inc. (BETRF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.03 CAD | 73.6% |
| 2023 | -0.10 CAD | 37.5% |
| 2022 | -0.16 CAD | 88.06% |
| 2021 | -1.34 CAD | -0.75% |
| 2020 | -1.33 CAD | -31.68% |
| 2019 | -1.01 CAD | -5301.07% |
| 2018 | -0.02 CAD | 98.28% |
| 2017 | -1.09 CAD | 29.22% |
| 2016 | -1.54 CAD | -79.07% |
| 2015 | -0.86 CAD | -437.5% |
| 2014 | -0.16 CAD | -267.54% |
| 2013 | 0.10 CAD | -77.26% |
| 2012 | 0.42 CAD | 138.89% |
| 2011 | -1.08 CAD | -2038.61% |
| 2010 | -0.05 CAD | 83.17% |
| 2009 | -0.30 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - CAD | 73.6% |
| 2024 Q3 | -0.00 CAD | 81.72% |
| 2024 Q1 | -0.01 CAD | -284.0% |
| 2024 Q4 | -0.01 CAD | -558.82% |
| 2024 Q2 | -0.01 CAD | 3.13% |
| 2023 Q2 | -0.01 CAD | 70.38% |
| 2023 Q1 | -0.03 CAD | 26.51% |
| 2023 Q4 | -0.00 CAD | 98.65% |
| 2023 Q3 | -0.06 CAD | -485.15% |
| 2023 FY | - CAD | 37.5% |
| 2022 Q3 | -0.03 CAD | 44.09% |
| 2022 FY | - CAD | 88.06% |
| 2022 Q2 | -0.05 CAD | -3.79% |
| 2022 Q1 | -0.04 CAD | 91.04% |
| 2022 Q4 | -0.05 CAD | -78.46% |
| 2021 Q3 | -0.25 CAD | -175.94% |
| 2021 FY | - CAD | -0.75% |
| 2021 Q1 | 0.00 CAD | 100.61% |
| 2021 Q2 | -0.09 CAD | -2484.21% |
| 2021 Q4 | -0.50 CAD | -100.0% |
| 2020 Q3 | -0.15 CAD | 46.43% |
| 2020 Q2 | -0.28 CAD | -47.37% |
| 2020 Q1 | -0.19 CAD | -151.99% |
| 2020 FY | - CAD | -31.68% |
| 2020 Q4 | -0.62 CAD | -313.33% |
| 2019 Q4 | -0.08 CAD | 84.61% |
| 2019 Q2 | -0.22 CAD | 8.33% |
| 2019 Q3 | -0.49 CAD | -122.73% |
| 2019 Q1 | -0.24 CAD | -401.04% |
| 2019 FY | - CAD | -5301.07% |
| 2018 Q2 | -0.00 CAD | 98.44% |
| 2018 FY | - CAD | 98.28% |
| 2018 Q4 | -0.05 CAD | -136.85% |
| 2018 Q3 | 0.13 CAD | 14544.44% |
| 2018 Q1 | -0.06 CAD | 51.92% |
| 2017 FY | - CAD | 29.22% |
| 2017 Q1 | -0.56 CAD | 45.1% |
| 2017 Q4 | -0.12 CAD | 29.41% |
| 2017 Q2 | -0.20 CAD | 64.29% |
| 2017 Q3 | -0.17 CAD | 15.0% |
| 2016 Q4 | -1.02 CAD | -84900.0% |
| 2016 FY | - CAD | -79.07% |
| 2016 Q1 | -0.20 CAD | -66.67% |
| 2016 Q2 | -0.37 CAD | -85.0% |
| 2016 Q3 | -0.00 CAD | 99.68% |
| 2015 Q3 | -0.14 CAD | -344.44% |
| 2015 FY | - CAD | -437.5% |
| 2015 Q1 | 0.10 CAD | 1951.85% |
| 2015 Q2 | -0.03 CAD | -131.5% |
| 2015 Q4 | -0.12 CAD | 14.29% |
| 2014 Q2 | -0.01 CAD | 1.46% |
| 2014 Q4 | -0.01 CAD | 95.5% |
| 2014 Q3 | -0.12 CAD | -788.89% |
| 2014 Q1 | -0.01 CAD | 29.02% |
| 2014 FY | - CAD | -267.54% |
| 2013 Q2 | -0.03 CAD | -117.2% |
| 2013 FY | - CAD | -77.26% |
| 2013 Q1 | 0.20 CAD | 174.07% |
| 2013 Q3 | -0.02 CAD | 50.58% |
| 2013 Q4 | -0.02 CAD | -13.53% |
| 2012 Q3 | 0.04 CAD | -7.09% |
| 2012 Q2 | 0.04 CAD | -93.42% |
| 2012 FY | - CAD | 138.89% |
| 2012 Q4 | -0.27 CAD | -835.69% |
| 2012 Q1 | 0.60 CAD | 165.93% |
| 2011 Q2 | -0.02 CAD | -56.64% |
| 2011 Q4 | -0.91 CAD | -14344.44% |
| 2011 Q3 | -0.01 CAD | 64.41% |
| 2011 FY | - CAD | -2038.61% |
| 2011 Q1 | -0.01 CAD | -56.94% |
| 2010 Q4 | -0.01 CAD | -22.03% |
| 2010 Q2 | -0.03 CAD | -492.59% |
| 2010 FY | - CAD | 83.17% |
| 2010 Q3 | -0.01 CAD | 81.56% |
| 2010 Q1 | -0.01 CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |